Dermatol. praxi. 2010;4(3):135-138

Eczema herpeticum in childhood

MUDr.Zuzana Havlíčeková, PhD., MUDr.Miloš Jeseňák, Ph.D., MBA, doc.MUDr.Ľubica Jakušová, PhD., prof.MUDr.Peter Bánovčin, CSc.
Klinika detí a dorastu, MFN a JLF UK, Martin

Eczema herpeticum is the dissemination of herpes simplex virus infection in the setting of pre-existing atopic eczema. Early diagnosis

and antiviral treatment limit disease duration, mortality and morbidity, but it´s still potentially serious and life-threatening complication,

especially in young children and immunocompromised patients. Authors present current opinions in etiopathogenesis, clinical signs

and management of eczema herpeticum.

Keywords: eczema herpeticum, atopic eczema, children, herpes simplex virus

Published: November 20, 2010  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Havlíčeková Z, Jeseňák M, Jakušová Ľ, Bánovčin P. Eczema herpeticum in childhood. Dermatol. praxi. 2010;4(3):135-138.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. De Benedetto A, Agnihothri R, McGirt L, Bankova LG, Beck LA. Atopic Dermatitis: A Disease Caused by Innate Immune Defects? J Invest Dermatol 2009; 129: 14-30. Go to original source... Go to PubMed...
    2. Dokmeci E, Herrick CA. The immune system and atopic dermatitis. Semin Cutan Med Surg 2008; 27: 138-143. Go to original source... Go to PubMed...
    3. Elias PM, Steinhoff M., ,Outside-to-inside" (and Now Back to, ,Outside) Pathogenic Mechanisms in Atopic Dermatitis. J Invest Dermatol 2008; 128: 1067-1070. Go to original source... Go to PubMed...
    4. Engler RJ, Kenner J, Leung DY. Smallpox vaccination: Risk considerations for patients with atopic dermatitis. J Allergy Clin Immunol 2002; 110: 357-365. Go to original source... Go to PubMed...
    5. Habif TP. Clinical Dermatology. Edinburgh: Mosby, 2004: 1024 s.
    6. La Grutta S, Richiusa P, Pizzolanti G, Mattina A, Pajno GB, Citarrella R, Passalacqua G, Giordano C. CD4 (+) IL-13 (+) cells in peripheral blood well correlates with the severity of atopic dermatitis in children. Allergy 2005; 60: 391-395. Go to original source... Go to PubMed...
    7. Luger TA, Lahfa M, Fölster-Holst R, Gulliver WP, Allen R, Molloy S. Long-term safety and tolerability of pimecrolimus cream 1 % and topical corticosteroids in adults with moderate to severe atopic dermatitis. J Dermatol Treat 2004; 15: 169-178. Go to original source... Go to PubMed...
    8. Ogg G. Role of T cells in the pathogenesis of atopic dermatitis. Clin Exp Allergy 2008; 39: 310-316. Go to original source... Go to PubMed...
    9. Studdiford JS, Valko GP, Belin LJ, Stonehouse AR. Eczema herpeticum: making the diagnosis in the emergency department. J Emerg Med 2008 [ahead of print].
    10. Wahn U, Bos JD, Goodfield M, Caputo R, Papp K, Manjra A, Dobozy A, Paul C, Molloy S, Hultsch T, Graeber M, Cherill R, de Prost Y; Flare Reduction in Eczema with Elidel (Children) Multicenter Investigator Study Group. Efficacy and safety of pimecrolimus cream in the long-term management of atopic dermatitis in children. Pediatrics 2002; 110(1 Pt 1): e2. Go to original source... Go to PubMed...
    11. Wollenberg A, Wagner M, Günther S, Towarowski A, Tuma E, Moderer M, Rothenfusser S, Wetzel S, Endres S, Hartmann G. Plasmacytoid dendritic cells: a new cutaneous dendritic cell subset with distinct role in inflammatory skin diseases J Invest Dermatol 2002; 119: 1096-1102. Go to original source... Go to PubMed...
    12. Wollenberg A, Zoch C, Wetzel S, Plewig G, Przybilla B. Predisposing factors and clinical features of eczema herpeticum: A retrospective analysis of 100 cases. J Am Acad Dermatol 2003; 49: 198-205. Go to original source... Go to PubMed...

    Return to the content


    Dermatology for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.